Frequently Asked Questions

Answers to common questions about visits, conditions and treatment.

General

Dr. Gould sees patients at Greater Boston Urology in Milton, Massachusetts. The office location is listed on the About page. To schedule, use the request form or email [email protected]. Confirm any additional office locations and days

It depends on your insurance plan. Check with your insurer, and with Greater Boston Urology when you book.

Yes. Visits and records are handled by Greater Boston Urology and protected under HIPAA. Please don't send personal health details through this website's contact form.

Photo ID, your insurance card, a list of medicines and supplements, past PSA results, and any imaging or biopsy reports. A short bladder diary helps if nighttime urination is your main concern.

No. It is general education. It does not create a doctor–patient relationship. For a medical emergency, call 911.

Enlarged Prostate (BPH)

No. BPH is a non-cancerous enlargement of the prostate. A man can have both, which is why new urinary symptoms deserve an evaluation.

Alpha-blockers often help within days to weeks. 5-alpha reductase inhibitors shrink the prostate slowly; the finasteride label notes that a trial of at least six months was generally needed.1

It depends on the procedure. In the L.I.F.T. study, no men treated with prostatic urethral lift developed new, lasting erection or ejaculation problems.2 Operations such as TURP often cause retrograde ejaculation.

Often, yes, if they're mild and not getting worse. Regular check-ins matter, because untreated blockage can sometimes lead to retention, infections or bladder stones.

Yes. The AUA's 2026 guideline covers many procedures, including prostatic urethral lift, water vapor therapy, laser treatments, robotic waterjet treatment and prostate artery embolization.3

PSA & Prostate Cancer Screening

The AUA/SUO guideline says a baseline PSA may be offered between 45 and 50, and screening should be offered from 40 to 45 for men at higher risk.4 The USPSTF calls screening an individual decision for men 55 to 69.5

An enlarged prostate, prostatitis and urinary infections are common causes. That's why a high result is often repeated and looked at in context.

Yes. Finasteride lowers PSA by about half within six months, so results must be interpreted with that in mind.1 Tell whoever orders your PSA if you take finasteride or dutasteride.

Not always. Next steps often include a repeat test and, in many cases, a prostate MRI. The decision is shared and depends on your overall risk.

Guidelines suggest personalizing or stopping screening based on age, health, life expectancy, past results and your preferences.4 The USPSTF recommends against PSA screening at 70 and older.5

Sources and references

  1. PROSCAR (finasteride) tablets, US prescribing information. Revised 03/2026. View source
  2. Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. J Urol. 2013;190(6):2161-2167. View source
  3. Goueli R, Badlani GH, Welliver C, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline (2026) part III: procedural/surgical management. J Urol. 2026;216(2):161-170. View source
  4. Wei JT, Barocas D, Carlsson S, et al. Early detection of prostate cancer: AUA/SUO guideline part I: prostate cancer screening. J Urol. 2023;210(1):46-53. View source
  5. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(18):1901-1913. View source

Ready to talk about your prostate or urinary health?

Start with a private conversation with Dr. Gould at Greater Boston Urology in Milton.

Request an Appointment